Approved Company
Redoxis
Address: NO DATA
Website: NO DATA
Country(s): Sweden
Supported Region(s): Europe
Description

Redoxis Founded in Sweden in 2007, the company focuses on preclinical development of small molecules that target molecular pathways in the immunological responses associated with autoimmune diseases such as Rheumatoid Arthritis (RA) and Multiple Sclerosis (MS).

Service Category(s)
Key Service(s)
Life Science Sector
Certificates
NO DATA